Eye health composition

A method of treating an eye pathology caused by an overexpression of a vascular endothelial growth factor (VEGF) pathway in a subject in need thereof, the method comprising:

• administering to the subject a daily dose composition consisting of:
• 120 mg to 240 mg of vitamin C;
• 10 mg to 500 mg of vitamin E;
• 5 mg to 100 mg of zinc;
• 0.2 mg to 10 mg of copper;
• 2 mg to 50 mg of the lutein;
• 0.5 mg to 10 mg of zeaxanthin;
• fish oil comprising:
• 172 mg to 380 mg of EPA;
• and
• 190 to 366 mg of DHA;
• and
• 30 to 200 mg of resveratrol,
• wherein said eye pathology is selected from the group consisting of exudative age-related macular degeneration (AMD), retinal venous occlusion, macular edema, diabetic macular edema, myopia, diabetic retinopathy, neovascular glaucoma, and corneal neovascularization.